Related by context. All words. (Click for frequent words.) 62 compares favorably 60 compared 57 comparable 55 compare favorably 53 compares 53 compares unfavorably 53 comparedwith 50 Compared 50 ROAE 50 Realised Earnings 49 compare unfavorably 49 inhospital mortality 48 median survivals 48 comparedto 48 OCF margin 47 Negatively impacting 47 LTM EBITDA ratio 47 PDP MLR 47 Leverage ratios 46 A' rated 46 seroprotection 46 EDITDA 46 confidence intervals CIs 46 EBITD 46 Fitch BBB medians 46 Comparing 46 yearago 46 Electro Rent NASDAQ ELRC 45 Merckx Hinault Miguel Indurain 45 Herpes infections 45 nonsignificant difference 45 uninfected chimps 45 excluding exceptionals 45 percentin 45 Ps.4 45 FHLB borrowings decreased 45 was#.# 45 Adjusted EBITDA1 45 Gini coefficients 45 comapred 45 % CI #.#-#.# [003] 45 SME Direkt poll 45 average equity ROAE 44 multivariable adjusted 44 totaled EUR#.# 44 #-#/# EUR 44 BBB medians 44 Operative mortality 44 FTE staffing 44 approximated 44 overyear 44 handily outpaced 44 Munghana Lonene Listenership 44 mean baseline A1C 44 lowerthan 44 of#.# [004] 44 ended September# 44 ARCALYST ® 44 anincrease 44 TEUR -# 44 lfl sales 44 diluted HEPS 44 QR #.#bn 44 consistently outperformed 43 E1 #Mn 43 Positively impacting 43 rebased OCF growth 43 thousand BOEPD 43 SFr#.# billion [002] 43 EBITA amounted 43 efficiency ratio teb 43 aq q 43 ratio ICER 43 flattish sequentially 43 identifying beta coefficient 43 EBIT beia 43 Thomson Reuters Datastream 43 of#.# [003] 43 Sees FY# revs 43 #OHD levels 43 prime RMBS 43 Dry whey 43 sameperiod 43 Ps.3 43 Molex NASDAQ MOLXA 43 1H FY# [002] 43 definite stent thrombosis 43 RGU additions 43 MMSE scores 43 handily outperformed 43 and#.# [001] 43 prioryear 43 fractional anisotropy 43 Adjusted Ebitda 43 nondiabetic patients 43 £ #.#m £ #.#m 43 undetectable HBV DNA 43 by#.# [001] 43 XIENCE V demonstrated 43 to#.# [006] 43 Ps.7 43 weakly correlated 43 microbiological eradication 43 % CI #.#-#.# [006] 43 preintervention 43 #compared 43 % CI #.#-#.# [007] 43 InterOil AMEX IOC 43 #.#per diluted 43 Truckload segment 43 Monro Muffler NASDAQ MNRO 43 CHF#.#bn [002] 42 ApoE4 carriers 42 oral diclofenac 42 SEK1 #m 42 totaled EUR#.#m 42 Currency translation negatively impacted 42 undepreciated assets 42 statistically indistinguishable 42 multivariate adjustment 42 resected pancreatic cancer 42 CROCS NASDAQ CROX 42 Nonperforming assets totaled 42 Eustat data 42 Loss severities 42 € #.#ma [003] 42 HY# 42 ratios compare favorably 42 from#.# [001] 42 average assets ROAA 42 operatingincome 42 highest quintile 42 RevPAR ADR 42 SKr#.#bn [003] 42 Colorectal cancer incidence 42 Thomson Reuters StarMine SmartEstimates 42 outperformed 42 MSEK -#.# 42 TFG CLO investments 42 HUF #.#bn [002] 42 QALY gained 42 NOTES Applicable 42 theprior 42 Nonaccrual loans totaled 42 #.#-#.# bln dkr [002] 42 th percentile 42 ROAA 42 onyear 42 NOI DSCR 42 Interrater reliability 42 Blended ARPU 42 CIM Standards differ 42 Kaplan Meier estimates 42 HUF#.# billion [002] 42 totaled E#.# 42 netsales 42 #Q/# [001] 42 #.#-# mln eur [001] 42 #-#.# mln [002] 42 μg L 42 versus 42 recompletions reactivations development 42 Floorcoverings retail 42 rebased revenue 42 Kronos TiO2 production 42 noninterest expense decreased 42 Stroke Scale 42 Contextual Value Added 42 Irrigation Segment 42 EBIT amounted 42 Energen NYSE EGN 42 locoregional recurrence 42 mmHg diastolic 42 Excluding OSIs 42 operating income1 42 multifamily delinquency 42 Silgan Holdings NASDAQ SLGN 42 Annualizing 42 MNOK #.# 42 Carreker Corporation improves 42 cancerous prostates removed 42 excluding nonrecurring 42 HOMA IR 42 EUR# mn [002] 42 down#.# [002] 42 ¥ #.#bn [004] 42 and#.# [002] 41 noninterest expense divided 41 yearon 41 cents ashare 41 respectively 41 Ezcorp NASDAQ EZPW 41 sharpest declines 41 #bp QoQ 41 Copart NASDAQ CPRT 41 -#.# Mio 41 Fitch DSCR 41 -#.# mg dL [001] 41 Stonemor Partners NASDAQ STON 41 #.# mil rub [002] 41 odds ratios ORs 41 ACR# responses 41 Clinical Diagnostics segment 41 BOEd 41 #.#/BOE [001] 41 YE# [002] 41 category medians 41 Pro forma Adjusted EBITDA 41 C diff infections 41 noncarriers 41 Key secondary endpoints 41 #.#/# [008] 41 Prepaid churn 41 yearover 41 Assessed valuation AV 41 Ag Eq oz 41 #.#/# [017] 41 Overall 41 adjusted 41 non conforming RMBS 41 colorectal cancer incidence 41 accruing restructured 41 Pharmacokinetic parameters 41 Medcath NASDAQ MDTH 41 binary restenosis 41 AirMedia NASDAQ AMCN 41 oral Hycamtin 41 +#.# pc 41 biopsy Gleason 41 surpassed 41 ug g 41 thefourth quarter 41 mcg albinterferon alfa 2b 41 serum urate 41 SEK#.#bn [003] 41 HOT Topic NASDAQ HOTT 41 ResiLogic model 41 tw telecom NASDAQ TWTC 41 PANSS total 41 persistency mortality 41 PLN #.#mn [001] 41 statistically significant p 41 #.#-#.# [002] 41 latent celiac disease 41 written NPW 41 PASI scores 41 fared 41 Thomson IBES consensus 41 AA medians 41 enhances comparability 41 Reputation Pulse 41 ASUR regulated 41 UPDRS scores 41 comparing 41 nonaccruals 41 adjusted2 41 demonstrated clinically meaningful 41 P ≤ 41 HbA 1c levels 41 passenger kilometers RPKs 41 SVR# 41 NIM compression 41 lopinavir r arm 41 CHF#.# billion [002] 41 RLEC adjusted EBITDA 41 £ #.#bn [002] 41 diameter stenosis 41 leukocyte count 41 Small Ordinaries Index 41 Inventories subtracted 41 closely correlated 41 AAA sovereigns 41 profit beia 41 ADCS CGIC 41 #.#ca [004] 41 SEK#.#bn [004] 41 Kerastick ® 41 urinary BPA 41 arterial thromboembolism 41 Horsehead NASDAQ ZINC 41 assets ROAA 41 yo y 41 baseline A1C 41 higherthan 41 upper quartile 41 pT3 41 at#.# [002] 41 compare 41 nasal symptom 41 dose pravastatin 41 QIV 40 Q#/# € 40 average 40 com pared 40 ascompared 40 oil equivalent MMBoe 40 AAA' rated 40 Hazard Ratio = 40 ¥ #.#b 40 #.#-#.# bln usd [002] 40 Aerovironment NASDAQ AVAV 40 corresponding 40 Normalised earnings 40 mIU ml 40 EBIDA 40 KRAS mutations occur 40 inbreeding coefficient 40 fiscal year# 40 adjusted1 net 40 BBB + BBB 40 Scifres punted six 40 oxycodone CR 40 Excluding goodwill impairment 40 downwardly adjusted 40 Cronbach alpha 40 extracapsular extension 40 to#.# [003] 40 noninterest expense totaled 40 #.#x #.#x [002] 40 9M FY# [001] 40 adjusted Ebitda 40 baseline serum creatinine 40 pro forma adjusted EBITDA 40 Unadjusted 40 ninemonths 40 RPX Composite 40 #.#ma [002] 40 Cognex NASDAQ CGNX 40 un levered 40 DAS# remission 40 thequarter 40 CHF#.#m [001] 40 FY#E EV EBITDA 40 spine BMD 40 Libbey AMEX LBY 40 Bcfe d 40 inhospital 40 mg BID dose 40 highest tertile 40 Align Technology NASDAQ ALGN 40 heps 40 NIKE NYSE NKE 40 Pro forma EPS 40 TRY#.# billion 40 annual HICP inflation 40 Sawlog prices 40 legalizing incest 40 postintervention 40 intraclass correlation coefficient 40 DAS# CRP 40 MEUR -#.# 40 Crosstex Energy NASDAQ XTXI 40 primary patency 40 Comparatively 40 Homefurnishing Retail industry 40 antiretroviral naïve 40 upticked 40 Zometa hazard 40 echocardiographic parameters 40 P TBV 40 Sees FY 40 yearearlier 40 CHD mortality 40 Ctrip.com International NASDAQ CTRP 40 baseline HbA1c 40 revenues teb 40 +#.# ppts 40 EUR2 #mn 40 pershare 40 YtD 40 lessened considerably 40 EBITANCE 40 Landstar System NASDAQ LSTR 40 #.#-#.# bln usd [004] 40 LTM adjusted EBITDA 40 Stent thrombosis 40 ROAs 40 F2Q EPS 40 Noninterest expense totaled 40 serum PTH 40 DVFA SG 40 quarter offiscal 40 denosumab subcutaneously every 40 morphometric vertebral fractures 40 Noninterest expense decreased 40 Variable Interest Entities VIEs 40 baseline CD4 + 40 Elizabeth Arden NASDAQ RDEN 40 pulmonary capillary wedge 40 reports Q3 adj 40 SmartEstimate 40 MMCFE d 40 #.#:# #.#:# [001] 40 rs# [002] 40 HbA1C levels 40 beta coefficient 40 FQ = fiscal 40 Replikin Count 40 mainline PRASM 40 confidence interval #.#-#.# 40 normalized EPS 40 #.#/ADR increasing 40 Keeps outperform 40 stressed DSCR 40 HER2 homodimer levels 40 #.# crore [002] 40 mmol l 40 International NASDAQ HSII 40 USD#.#m [007] 40 billable headcount 40 invoiced shipment 40 prolactin elevation 40 CHD CVD 40 DKK#.# billion [002] 40 GDP shrank 40 Nonfarm productivity 40 YoverY 40 SME Direkt 40 npat 40 #.#/diluted share 40 Holdings NYSE KFN 40 #.#-#.# mln [004] 40 abover 40 symptomatic intracerebral hemorrhage 40 increaseof 40 sales outstanding DSOs 40 Comparable 40 OC ZIPs 40 Andersons NASDAQ ANDE 40 inforce premiums 40 #ppb gold 40 mL/min/#.# m 2 40 Agilysys NASDAQ AGYS 40 bps YoY 40 prospectively evaluated 40 LTL tonnage 40 coverage ratios DSCR 40 Joseph Piotroski benchmark 40 ebita 40 serum ferritin 40 undepreciated book 40 trended upwards 40 Diluted HEPS 40 excluding nonrecurring items 40 asset allocators overweight 40 Haverty Furniture NYSE HVT 40 NBV margin 40 analyst Mats Liss 40 approx. USD#.#m [001] 39 topped analystsâ 39 mL/min/#.# m2 39 QIDS SR 39 pooled comparator 39 achieved ACR# 39 avearge 39 SMMI 39 #.#bln rbl [003] 39 Courier NASDAQ CRRC 39 HG LV 39 EBT amounted 39 9per cent 39 preoperative PSA 39 Saeed al Liby 39 Medivation NASDAQ MDVN 39 Graduation Success Rate GSR 39 anemia hemoglobin 39 LKQ NASDAQ LKQX 39 Mainline RPMs 39 Median survival 39 NEVO ™ 39 ACR# response 39 Core noninterest expense 39 affective psychosis 39 reasonably determinable 39 CY#E EPS 39 TTM Technologies NASDAQ TTMI 39 lowest quintile 39 slight upticks 39 Ishak fibrosis score 39 fullyear outturn represents 39 femoral neck BMD 39 elevated LDH 39 double digit growths 39 reweighted 39 EUR -#.# -#.# [002] 39 Cdn#.# cents per 39 capacity utilisations 39 Adjusted EBTIDA 39 HealthGrades analyzed 39 reflecting 39 Sunspider 39 Tables reconciling 39 pCR 39 Adjusted EBITDAR margin 39 BMI z 39 Consensus Estimate 39 reports Q4 adj 39 detached bungalows 39 EUR1 #.#m 39 faired 39 TCE TA 39 H#/# EUR 39 Universal Display NASDAQ PANL 39 anniversaried 39 comparison 39 SME Direkt survey 39 andoperating 39 LV dysfunction 39 plus aztreonam 39 ECU netbacks 39 NOK#.# [006] 39 LTM EBITDA 39 annualizes 39 % Confidence Interval 39 ACEI ARB 39 outsold HD DVD 39 lowest quartile 39 Ebidta 39 topped 39 sm Nasdaq NDAQ 39 Constant Prepayment Rate 39 #.# perdiluted 39 FHLB advances decreased 39 Ps.1 39 consolidated OIBDA margin 39 chemically synthesized pills 39 elevated ALT 39 outstanding DSOs 39 nMeanwhile 39 #.#pc yr yr 39 nmol l 39 achieved statistical significance 39 #.#-#.# bln eur [005] 39 #.#m hectoliters [001] 39 hormone receptor negative 39 Hazard Ratio HR 39 #.#mln rub [004] 39 6MWD 39 cytogenetic analyzes 39 pre exceptionals 39 sahre 39 Particularly pleasing 39 Kris Kippers 39 ay y 39 sacked Kirk Cousins 39 prevalences 39 Variable annuity deposits 39 mg XP# 39 H#'# 39 GBP #.#m [003] 39 Detailed breakdowns 39 Henry Schein NASDAQ HSIC 39 #bps yoy [001] 39 Complication rates 39 Specialized REITs industry 39 Payout ratios 39 VcMP 39 ZAR#.# billion [002] 39 OSIs 39 interobserver 39 INR#.#bn [004] 39 approx. USD# 39 upfrom 39 E#.#m [005] 39 Baseline characteristics 39 A#.# #.#c 39 PlexCrown 39 of#.# [002] 39 widescreen #.#:# aspect 39 #.#mln rub [006] 39 ay y basis 39 PMPM basis 39 vintage subprime RMBS 39 Koppers Holdings NYSE KOP 39 Earning Per Share 39 combined 39 continuingoperations 39 ofapproximately 39 marketed workover rigs 39 IBDQ 39 PlexCrown ratings 39 mishandled baggage rate 39 ION Geophysical IO 39 SEK#.#m [001] 39 Questcor Pharmaceuticals NASDAQ QCOR 39 Celsentri Selzentry 39 9M FY# [002] 39 statewide unadjusted jobless 39 Thomson Reuters DataStream 39 ay y decline 39 Ps.2 39 adjusted OIBDA margin 39 RO#.# [006] 39 value ratios LTVs 39 PrivateBancorp NASDAQ PVTB 39 symptomatic GERD 39 -#.# log# copies mL 39 confirmed thrombotic cardiovascular 39 Annualised 39 CI #.#-#.# [002] 39 #mm Hg 39 coinfected 39 ııı#.# billion [002] 39 low dose Iluvien 39 FAD payout ratio 39 dollar denominated Libor 39 percet 39 VirnetX Holding AMEX VHC 39 #basis points 39 6MW distance 39 SOIR readings 39 RONW 39 h Represents 39 XIENCE V PROMUS Stent 39 passenger RASM 39 Recurring royalties 39 Rs.#.#cr 39 CHF #'#'# 39 Ps.#.# [006] 39 Losers outnumbered winners 39 Ingenix manipulated 39 beta coefficient included 39 jumbo adjustable IO 39 StarMine Professional 39 contrasted 39 aP S 39 decreased 39 nmol L. 39 EPADS 39 YonY 39 anaverage 39 atheroma volume 39 reinsurance reinstatement 39 NASDAQ CTCM ranks 39 JPY#.# billion [001] 39 MagTex acquisition 39 dose dabigatran 39 corresponding period 39 calculate DSO uses 39 CKX NASDAQ CKXE 39 outdelivered 39 outproduced 39 OREO write downs 39 consolidated OIBDA 39 rose# 39 Return TSR 39 #bps qoq [001] 39 millioncompared 39 regression coefficient 39 intact parathyroid hormone 39 retrospectively analyzed 39 sunitinib sorafenib 39 NCSLT #-# 39 RO#.# [001] 39 beat analystsā 39 increa sed 39 colorectal neoplasia 39 BPH symptom 39 intraobserver 39 Wireline adjusted EBITDA 39 Select Comfort NASDAQ SCSS 39 MD Buyline IDC 39 y oy 39 Leasable area 39 LFQ gross 39 HUF #.#bn [004] 39 CHF #'# [002] 39 Statscan revised 39 Available Seat Kilometres 39 HDL glucose 39 #.#-#.# [011] 39 Offensive Efficiency 39 #.# [027] 39 per share1 39 SYNNEX NYSE SNX 39 CLP#.# trillion 38 glycated hemoglobin HbA1c 38 Telmex interconnection 38 CIN2 + 38 correlated 38 #.# DCOH 38 AFFO payout ratio 38 segment binary restenosis 38 proforma revenues 38 CABG p = 38 mm Hg diastolic 38 lumbar spine BMD 38 Billable headcount 38 Forecasts ranged 38 #.# bln sfr [002] 38 outselling HD DVD 38 cervix uteri 38 SPECint rate# 38 Gasoline inventories shrank 38 SEISMIC Trial 38 Headline PBIT 38 ACR# ACR# 38 airfreight tonnage 38 ROE ROA 38 Consolidated EBITDA Margin 38 #.#points [003] 38 Baa rated 38 Assets ROA 38 carboplatin chemotherapy 38 angiographic outcomes 38 GBP#.# billion [001] 38 Free Survival PFS 38 Fully diluted EPS 38 micrograms mL 38 Pro forma EBITDA 38 univariate 38 Annualized ROE 38 LTL #.#mn [001] 38 offiscal 38 Fasting blood glucose 38 Extrapolated 38 FEV1 forced expiratory 38 £ #.#ma [005] 38 invasive ductal 38 % CI #.#-#.# [002] 38 R# 9m [001] 38 kboe d 38 P = .# 38 #.#/ADR 38 Moody Aa2 38 CR nPR 38 Jarden NYSE JAH 38 #.#percentage 38 endoscopic remission 38 jackup utilization 38 Excluding nonrecurring items 38 avg. 38 invasive carcinomas 38 hsCRP levels 38 AXT AXTI 38 monthsended 38 approximating 38 IPSS 38 E#.#m [002] 38 .#:# 38 Multivariate analysis revealed 38 Rigid PCB shipments 38 urinary albumin excretion 38 per ADS EPADS 38 Available Seat Kilometres ASKs 38 underwent surgical resection 38 aged ≥ 38 MRSA bloodstream infection 38 μg g 38 Eurozone ZEW 38 2Y yields 38 Aprovel R 38 #.#ma [005] 38 quartile 38 +#.# pp 38 KRAS wild 38 USD#.#m USD#.# per [002] 38 TTM gross 38 Industrial Conglomerates industry 38 Fuqi International NASDAQ FUQI 38 advanced adenoma 38 #.#m #.#m [004] 38 Individual Annuities segment 38 obstructive CAD 38 EBITDAA 38 MNOK #,# 38 FCDU loans 38 infliximab monotherapy 38 #-#.# mln eur 38 consolidated PRASM 38 outperforming 38 Dollar Tree NASDAQ DLTR 38 Forthe 38 percentfrom 38 wateriest 38 statistically significant p = 38 indicates optimists outnumber 38 Repliform R revenues 38 statistically significant predictor 38 arterial thromboembolic events 38 Team NASDAQ TISI 38 ALT elevation 38 OPANA franchise 38 DLQI 38 franc depreciated 38 markedly 38 confirmed CCyR 38 Endologix NASDAQ ELGX 38 rs# [004] 38 CCyR 38 viral titers 38 assets RoA 38 Explosive Metalworking segment 38 DPAC amortization 38 downwardly revising 38 Q4 F# 38 multivariable analyzes 38 #.#-#.# bln dkr [001] 38 fiftieth percentile 38 parous women 38 capitalized minimums 38 TEB adjustment 38 Atkins dieters cardiovascular 38 tb d 38 console outsold 38 pravastatin therapy 38 baseline FEV1 38 thanexpected 38 Dhs1 #m 38 SYKES Enterprises NASDAQ SYKE 38 MMCFEPD 38 CVD mortality 38 -#.# mg dL [002] 38 -hooker Marius Tincu 38 outpacing 38 serum lipid levels 38 Preoperatively 38 totaled MEUR 38 QM MSP 38 SEK#.#m [002] 38 univariate analysis 38 Postpay ARPU 38 Q1 LY 38 Microsoft.com attract 38 JPY#.# [002] 38 esophagus bladder 38 EBITDAO 38 bottom quintile 38 PLT migration 38 Omnova Solutions NYSE OMN 38 USD #.#bln [001] 38 Prepaid ARPU 38 pro forma MADS coverage 38 outpaced 38 UTi Worldwide NASDAQ UTIW 38 Leverage Tier 38 clinicopathological 38 Banco Azteca Mexico 38 comscore 38 Reiterates outperform 38 netincome 38 unformulated vaccine 38 ShengdaTech NASDAQ SDTH 38 investigational saxagliptin 38 eHealth NASDAQ EHTH 38 Doxil alone 38 Including discontinued operations 38 percentto 38 attain statistical significance 38 ADAS cog 38 GVIC consolidated 38 acute cholecystitis 38 normalized EBITDA 38 analystsâ € ™ 38 oncologic outcomes 38 REYATAZ r arm 38 Recurring EBITDA 38 Cosan NYSE CZZ 38 Phosphates segment 38 Dhs2 #m 38 annualising 38 Unitrin Direct segment 38 MMSE score 38 postpay churn 38 clinico pathological 38 CIRe 38 Rs.#.# crores [005] 38 Segment PTOI 38 Unfavourable Changes 38 #.#-# mln [001] 38 PBDIT 38 AXT NASDAQ AXTI 38 Likewise Tunnicliffe 38 mean ± SEM 38 BioDelivery Sciences NASDAQ BDSI 38 albumin excretion rate 38 #.# [001] 38 systemwide REVPAR 38 Romaco segment 38 #.#pc [004] 38 Detached bungalows 38 APACHE II 38 neglible 38 Rectal cancer 38 fourteenth consecutive 38 Per capita GDP 38 PLT departures 38 EUR#.#M [002] 38 Allegiant Travel NASDAQ ALGT 38 - Total noninterest [006] 38 biochemical recurrence 38 +#,# % [002] 38 Disaggregating 38 seropositivity 38 LIFO provision 38 Adjusted OIBDAN 38 strategies KPIs metrics 38 glipizide plus 38 Q# revs 38 interpretability 38 missed analystsâ 38 SEK -#.# [001] 38 Nasdaq adv dec 38 Avea Turk Telekom 38 Chilled pork 38 cumulates 38 Cash Pay Constrained 38 urinary iodine 38 Partially offset 38 Zoltek NASDAQ ZOLT 38 mmol liter 38 #.#percentage points 38 #,# c [002] 38 optionsXpress NASDAQ OXPS 38 SR#.#m 38 #.#/#.# [018] 38 excluding BIBP 38 pecentage 38 Univariate analysis 38 slight downtick 38 Risk Weighted 38 Handset shipments 38 statistical significance p 38 OSV segment 38 #.#mg/dL 38 rated Caa1 38 € #.#bn [008] 38 comparably rated 38 ISK #.#bn EUR 38 hip BMD 38 ‰ ¥ 38 LPA gene 37 ¥ #.#bn [003] 37 Chris Landsea meteorologist 37 μmol L 37 highly emetogenic 37 Raheem Suleman Talk 37 Composite Leading Indicator 37 denotes contraction 37 EPADR estimate 37 -#.# [005] 37 ¥ #.#bn [002] 37 Seasonally unadjusted 37 LAE reserves 37 FFO payout ratio 37 Breslow thickness 37 Median PFS 37 Sees FY# adj EPS 37 -#.# log# 37 exceeded 37 kroner euro#.# [002] 37 Non GAAP adjusted EBITDA 37 equaled 37 Date -Coship Electronics 37 completely resected 37 overperformed 37 German Purity Laws 37 beat analystsâ 37 #.#/# [005] 37 per capita GNI 37 Ultrapetrol Bahamas NASDAQ ULTR 37 9bp 37 SGRQ 37 Smecta ® 37 rate1 37 Diversified REITs industry 37 Time Charter Equivalent 37 SquareTrade Care Plans 37 CPI NYSE CPY 37 besting 37 scrotal circumference 37 bunion deformity 37 Normalised headline 37 Scansource NASDAQ SCSC 37 Rs5 #cr 37 mercury mmHg 37 operating EBIDA 37 Q#/# EUR [002] 37 Himax Technologies NASDAQ HIMX 37 Refinery utilization rebounded 37 -#.# [002] 37 Omnicell NASDAQ OMCL 37 SEK -#.# -#.# [002] 37 β = 37 ADCS ADL 37 progression TTP 37 BRCA2 mutation carriers 37 excluding AOCI 37 B piece resecuritizations 37 lowest tertile 37 depressive symptom 37 Valueclick NASDAQ VCLK 37 FY1 37 Novagold Resources AMEX NG 37 #.#-#.# bln eur [003] 37 D2E deals 37 Interactive Brokers NASDAQ IBKR 37 carotid artery narrowing 37 virtually unchanged